Latest news

ClinicalSeptember 7, 2026

Ziihera Delivers Second Survival Win in Advanced HER2-Positive Stomach Cancer Trial

Jazz Pharmaceuticals has reported a second positive overall survival result for Ziihera (zanidatamab-hrii) in a Phase 3 study of...

InsightsSeptember 7, 2026

How Synthetic Data Is Changing Clinical Research

Executive Summary Clinical research depends on data, but access to high-quality patient data remains one of the industry's persistent challenges. Clinical...

RegulatorySeptember 3, 2026

FDA Approves Eli Lilly’s Mounjaro to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes

The U.S. Food and Drug Administration (FDA) has approved Eli Lilly’s Mounjaro (tirzepatide) to reduce the risk of major...

CommercialSeptember 3, 2026

Roche’s Genentech Partners With DualityBio on ADCs Designed to Address Cancer Drug Resistance

Roche’s Genentech has entered into a collaboration and licensing agreement with Shanghai-based DualityBio to develop antibody-drug conjugates (ADCs) intended...

InsightsSeptember 3, 2026

Top 10 Innovations in Target Identification in Drug Development

Executive Summary Target identification is one of the most consequential...

CommercialSeptember 3, 2026

Cureety Buys Out AI-Focused Oncology Firm Reimagine Care

Precision oncology care firm Cureety has acquired artificial intelligence-powered...

CommercialSeptember 3, 2026

Novartis and Alteogen sign a $3.2 billion subcutaneous medication delivery agreement

With South Korea's Alteogen, Novartis has secured access to the biotech's exclusive subcutaneous drug delivery platform, ALT-B4, through an...

InsightsSeptember 3, 2026

Top 10 Data Governance Priorities for Life Sciences Leaders

Executive Summary Data has become one of the most important strategic assets across the life sciences industry. Pharmaceutical and biotechnology...

InsightsSeptember 3, 2026

Agentic AI in Life Sciences

Executive Summary Artificial intelligence in life sciences is moving beyond systems that simply generate answers or analyze information. The next stage...

ClinicalSeptember 2, 2026

Novartis Reports Positive Phase 3 Results for Rhapsido in Relapsing Multiple Sclerosis

Novartis has reported positive results from two phase 3...

ManufacturingSeptember 2, 2026

ArsenalBio Lays Off 99 Employees and Shifts Focus to In Vivo CAR-T Programs

Arsenal Biosciences (ArsenalBio) is reducing its workforce by 99...

RegulatoryAugust 31, 2026

FDA Clears Jazz’s Ziihera for First-Line Treatment of HER2-Positive Gastroesophageal Cancer

Jazz’s ;The U.S. Food and Drug Administration has approved Jazz Pharmaceuticals’ Ziihera (zanidatamab-hrii) for previously untreated adults with unresectable,...

InsightsAugust 31, 2026

Why AI Agents Will Become Every Pharmaceutical Employee’s Copilot

Executive Summary Artificial intelligence is moving from a technology employees use to a capability that works alongside them. Pharmaceutical companies have...

InsightsAugust 31, 2026

How Digital Twins Are Transforming Drug Development

Executive Summary Drug development is becoming increasingly data-driven, computational, and personalized. Yet pharmaceutical companies still rely heavily on physical experiments...